What is low testosterone? The clinical definition most men (and many doctors) get wrong

Low testosterone, clinically called male hypogonadism, is a syndrome defined by persistent symptoms plus biochemical evidence of testosterone deficiency, usually below about 350 ng/dL total testosterone or 100 pg/mL free testosterone on accurate morning testing. A lab number alone is not a diagnosis, and symptoms alone are not enough either. That distinction explains why many men are overtreated by number only clinics and undertreated when a “normal” range is used to dismiss clear testosterone deficiency.

Key takeaways

• Male hypogonadism requires persistent symptoms plus biochemical evidence. We use 350 ng/dL total testosterone and 100 pg/mL free testosterone as decision thresholds when symptoms persist.^{[1] [7]}
• A man at 280 ng/dL is clearly low, but a man at 320 ng/dL can still have testosterone deficiency if symptoms are persistent and free testosterone is reduced.^{[1] [5] [7]}
• Testosterone should be measured in the morning, ideally between 07:00 and 11:00, because levels can be 20% to 30% higher early in the day and can fall with poor sleep, stress, and acute illness.^{[2] [7]}
• Only about 2% to 3% of circulating testosterone is free. SHBG binds roughly 40% to 60%, and albumin binds another 38% to 40%, which is why total testosterone can look “normal” while bioactive testosterone is low.^[4]
• LH and FSH must be measured with testosterone. High LH plus low testosterone suggests primary hypogonadism, while low or normal LH plus low testosterone suggests secondary hypogonadism, which may be treatable with Enclomiphene rather than lifelong testosterone replacement.^{[2] [7]}

What low testosterone actually means

Male hypogonadism is a clinical syndrome defined by persistent symptoms plus biochemical evidence of testosterone deficiency, not by a single lab result alone.^{[2] [3] [7]}

The relationship between symptoms and testosterone levels is the core of diagnosis: symptoms make the deficiency clinically meaningful, and accurate labs confirm that testosterone is truly low.

Hypogonadism means the body is not making or using enough testosterone for normal male function.

According to the Endocrine Society guideline, a diagnosis should be made only in men who have symptoms or signs consistent with testosterone deficiency and unequivocally low serum testosterone measured with accurate assays.^[2] The same principle appears in European guidance. Late onset hypogonadism must include persistent specific symptoms and biochemical evidence. The word “persistent” matters because a temporary dip after illness, sleep loss, or acute stress does not equal true testosterone deficiency.^{[3] [7]}

Why symptoms and labs both matter

A low number without symptoms is not enough, because treating a laboratory value that is not causing a clinical syndrome exposes a man to unnecessary medicalization. Symptoms without lab confirmation are also not enough, because fatigue, low mood, reduced exercise tolerance, and sexual symptoms can have many causes beyond low testosterone.^[2]

This dual requirement is where two common errors happen. Some direct to consumer clinics treat the number alone. Some conventional practices dismiss the patient because the number sits inside a broad reference range. Both approaches miss the actual definition of male hypogonadism. A man is not diagnosed by arithmetic alone. He is diagnosed by a pattern of symptoms plus confirmed biochemical testosterone deficiency.

According to the European Male Ageing Study, the syndrome of late onset hypogonadism emerged most clearly when low testosterone coexisted with a specific symptom pattern, especially sexual symptoms such as reduced libido, erectile dysfunction, and fewer morning erections.^[3] That does not mean sexual symptoms are the only symptoms that matter. It means they increase diagnostic specificity.

Symptoms and signals commonly include reduced libido, erectile dysfunction, fewer morning erections, low energy, reduced vitality, low mood, and shifts in body composition, but they must persist and fit the laboratory picture to support diagnosis.

Why “persistent” matters

Persistent means the problem remains present over time and is confirmed on repeat testing under the right conditions. Testosterone falls transiently during acute illness, after poor sleep, with calorie restriction, and under physiologic stress. If blood is drawn during that window, the result may reflect a temporary adaptive state rather than chronic hypogonadism.^{[2] [7]}

That is why a single low result is only the start of the evaluation. It is also why “I feel tired” is not enough by itself. The diagnosis is a syndrome. In clinical terms, a syndrome is a recognizable combination of symptoms, signs, and objective findings that fit together.

Why guidelines and lab ranges disagree

Differences between guidelines matter less than getting the basics right: symptoms, assay quality, repeat morning testing, and free testosterone when total testosterone does not match the clinical picture.^{[1] [7]}

In practice, diagnosis should rest on persistent symptoms, accurate assays, and repeat morning total testosterone, with free testosterone added when SHBG or the clinical picture makes total testosterone misleading.^[1] Some guidelines discuss different numeric cutoffs, but Veedma follows 350 ng/dL total testosterone and 100 pg/mL free testosterone as decision thresholds when symptoms persist.^[7]

Why the guidelines differ

The real differences across guidance are usually about emphasis, not fundamentals. Everyone agrees that symptoms matter, morning testing should be repeated, and assay quality affects interpretation. Free testosterone becomes especially important when SHBG is abnormal or when symptoms and total testosterone do not line up.^{[1] [7]}

A man at 280 ng/dL is clearly low. A man at 320 ng/dL needs a better workup, not a reflex dismissal. If symptoms are persistent, repeat morning levels remain low, or free testosterone is reduced, testosterone deficiency may still be present.^{[1] [5] [7]}

This is where many men fall through the cracks. If the clinician treats the lab as an on or off switch, the answer becomes artificially simple. Real endocrine physiology is not simple.

Why there is no sharp cutoff

There is no biologic cliff where a man is well at 351 ng/dL and hypogonadal at 349 ng/dL. Testosterone varies within the same man by time of day, sleep quality, acute illness, stress, and season. That is why borderline results should be repeated in the morning under stable conditions, especially in younger men, whose levels can be 20% to 30% higher earlier in the day.^{[2] [7]}

Assay methodology adds another layer of noise. Immunoassays and LC-MS/MS do not perform identically, and free testosterone immunoassays are particularly unreliable. According to the Endocrine Society, clinicians should use accurate assays and rigorously derived reference ranges when evaluating testosterone deficiency.^[2]

Population reference ranges also blur the picture. Broad adult ranges such as the harmonized 264 to 916 ng/dL interval are useful for standardization, but they are not age specific and they do not answer the clinical question on their own.^[6] At Veedma, broad ranges do not overrule persistent symptoms, repeat morning testing, or free testosterone; we use 350 ng/dL total testosterone and 100 pg/mL free testosterone as decision thresholds when symptoms persist. For a deeper explanation of why a report can look “normal” and still miss testosterone deficiency, see Why your testosterone test came back “normal” and why that might be wrong.

Why a “normal” test may still miss testosterone deficiency

Total testosterone alone can miss clinically relevant testosterone deficiency because only a small fraction of circulating testosterone is free and biologically available to tissues.^{[4] [5]}

Free testosterone is the unbound fraction that can readily enter tissues and activate androgen receptors. Bioavailable testosterone includes free testosterone plus the albumin bound fraction that can dissociate easily at the tissue level.

Total, free, and bioavailable testosterone

About 2% to 3% of testosterone circulates as free testosterone. Roughly 40% to 60% is tightly bound to sex hormone binding globulin, or SHBG, and another 38% to 40% is loosely bound to albumin.^[4] When SHBG rises, the free fraction can fall even if total testosterone stays in the reference range.

This is why a man can have “normal testosterone levels in men” on a routine report and still have real testosterone deficiency. Common reasons for higher SHBG include aging, liver disease, hyperthyroidism, and some medications. In that setting, total testosterone may overestimate what tissues can actually use.

A 2016 Journal of Clinical Endocrinology and Metabolism study found that low free testosterone was associated with hypogonadal signs and symptoms even in men whose total testosterone was normal.^[5] That finding captures a common clinical problem. Total testosterone can look acceptable while free testosterone tells a different story.

In many settings, calculated free testosterone using total testosterone, SHBG, and albumin by the Vermeulen formula gives more information than total testosterone alone.^[4] Direct equilibrium dialysis is the reference method for free testosterone measurement, but it is less widely available. Veedma prioritizes direct free testosterone measurement by equilibrium dialysis with LC-MS/MS, which avoids estimation error and does not require a separate SHBG calculation.

Why men with the same total testosterone feel different

Men with the same total testosterone can feel very different because testosterone action depends on more than the total concentration in blood. Tissue sensitivity varies. Androgen receptor signaling varies. SHBG changes free testosterone availability. Genetic variation, including androgen receptor CAG repeat length, may also alter how strongly a given testosterone level is felt at the tissue level.

Clinically, this means two things. First, a man with persistent symptoms at 400 ng/dL should not be dismissed without looking at free testosterone and the broader endocrine picture. Second, a man with 350 ng/dL and no symptoms does not automatically have male hypogonadism. For age specific context, see Low testosterone by age: What’s normal at 20, 30, 40, 50, and beyond.

Where the problem starts

The origin of testosterone deficiency determines treatment, which is why LH and FSH must be measured alongside testosterone at the initial evaluation.^{[2] [7]}

LH and FSH are pituitary hormones that signal the testes to make testosterone and support sperm production.

How it works is straightforward: the hypothalamus and pituitary send signals through LH and FSH, the testes produce testosterone, and tissues respond to the hormone that is actually available to them.

The three broad categories

Hypogonadism can arise from three broad categories. Primary hypogonadism begins in the testes. Secondary hypogonadism begins in the hypothalamus or pituitary, which means the brain is not sending an adequate signal. Functional hypogonadism reflects potentially reversible suppression of the axis from factors such as obesity, sleep loss, systemic illness, medications, or metabolic stress. Rare differentials such as androgen resistance can also impair testosterone action, but they are not a core category in a routine low testosterone diagnostic workup.

This framework matters because the same total testosterone result can represent very different diseases. The man with testicular failure and the man with an intact testis but poor pituitary signaling do not need the same treatment plan.

Why classification changes treatment

High LH plus low testosterone points to primary hypogonadism, where the brain is already signaling hard and the testes are not responding. Low or normal LH plus low testosterone points to secondary hypogonadism, where the testes may still work if the signal is restored.^{[2] [7]}

That distinction is not academic. It determines whether a man likely needs testosterone replacement or may be able to restore natural production with stimulation therapy such as Enclomiphene. Enclomiphene is most relevant when LH is below 8 mIU/mL and the problem is secondary or functional rather than primary. In that setting, it can raise endogenous testosterone while preserving spermatogenesis and testicular function. In primary hypogonadism, stimulating the axis will not fix testicular failure.

According to modern hypogonadism guidance, late onset hypogonadism still requires persistence. A temporary low value during illness or recovery should not be used to classify a man as permanently deficient.^{[2] [7]} For a fuller explanation of classification, see Primary vs secondary hypogonadism: where the problem starts and why it changes everything. For the full diagnostic workflow, see The complete low testosterone testing guide.

Any provider who skips LH and FSH is making a treatment decision without first defining the disease. That is why many men are steered straight to testosterone when they may actually be candidates for fertility preserving stimulation therapy.

What testosterone does across the body

Testosterone is a systemic hormone that affects muscle, bone, fat distribution, red blood cell production, sexual function, mood, cognition, cardiovascular health, and metabolic function.^{[2] [7]}

Systemic means the hormone influences multiple organ systems, not just one symptom.

Conditions linked to it can include sexual dysfunction, infertility, anemia, low bone density, increased fat mass, reduced lean mass, and broader metabolic or pituitary and testicular disorders depending on the cause.

According to the Endocrine Society guideline, testosterone deficiency is associated with reduced libido and sexual function, loss of body hair, low bone mineral density, anemia, decreased lean mass, increased fat mass, and reduced vitality in appropriately selected men.^[2] The European literature makes the same point in broader terms. Hypogonadism can adversely affect multiple organ functions and quality of life.^[7]

Why low testosterone is not just cosmetic

Testosterone helps maintain lean mass and supports normal fat distribution, which is why testosterone deficiency often shifts body composition toward more central fat and less muscle. It also supports bone remodeling. Severe or prolonged deficiency can contribute to bone loss. Testosterone stimulates erythropoiesis, which is red blood cell production, so deficiency can contribute to lower hemoglobin in some men.^[2]

Its effects on mood, cognition, and metabolic health are more nuanced, but they are clinically relevant. Men with hypogonadism often report lower energy, reduced motivation, and worse overall well being. Cardiometabolic associations are also strong, although association does not prove that low testosterone is always the primary cause. The practical point is simple. This is not a cosmetic complaint about “optimization.” Testosterone deficiency is a multisystem clinical condition.

That is why the question “what is low testosterone?” should never be answered with a number alone. The better question is whether a man has a persistent syndrome of testosterone deficiency, confirmed by accurate labs, interpreted in the context of how testosterone acts across the body.

Myth vs fact

Myth: A low lab number alone means you have low T

Fact: Male hypogonadism requires both persistent symptoms and biochemical evidence. A low number without symptoms is not sufficient for diagnosis.^{[2] [7]}

Myth: If your total testosterone is above the lab’s lower limit, low testosterone is ruled out

Fact: Diagnosis depends on persistent symptoms, repeat morning testing, and free testosterone when appropriate. We use 350 ng/dL total testosterone and 100 pg/mL free testosterone as decision thresholds when symptoms persist.^{[1] [5] [7]}

Myth: Total testosterone is all that matters

Fact: Only about 2% to 3% of testosterone is free, and elevated SHBG can lower biologically active testosterone even when total testosterone looks acceptable. Free testosterone can uncover hidden testosterone deficiency.^{[4] [5]}

Myth: Treatment choice is the same no matter where the problem starts

Fact: The source of the problem changes treatment completely. High LH plus low testosterone suggests primary hypogonadism, while low or normal LH plus low testosterone suggests secondary hypogonadism, where Enclomiphene may restore natural production and preserve fertility.^{[2] [7]}

What to do about it is to repeat morning testing, measure LH and FSH, check free testosterone when appropriate, look for reversible causes, and choose treatment based on whether the problem is primary, secondary, or functional.

Bottom line

Low testosterone is not simply a low lab number. It is male hypogonadism, a clinical syndrome that requires persistent symptoms, accurate morning hormone testing, and biochemical testosterone deficiency interpreted in context. For the full diagnostic and treatment roadmap, see the Low Testosterone hub.

Veedma offers a thorough diagnostic workup with an advanced men’s health panel using LC-MS/MS for total testosterone and equilibrium dialysis with LC-MS/MS for free testosterone, or a review of existing lab results you already have. Licensed providers build individualized treatment plans with Enclomiphene as first line for appropriate secondary or functional hypogonadism, the Enclomiphene plus Tadalafil combination tablet when erection or urinary symptoms are also present, and ongoing monitoring with protocol adjustments over time.

References

1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of urology. 2018;200:423-432. PMID: 29601923
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
3. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2010;95:2536-59. PMID: 20525905
4. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of clinical endocrinology and metabolism. 1999;84:3666-72. PMID: 10523012
5. Antonio L, Wu FC, O’Neill TW, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. The Journal of clinical endocrinology and metabolism. 2016;101:2647-57. PMID: 26909800
6. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. The Journal of clinical endocrinology and metabolism. 2017;102:1161-1173. PMID: 28324103
7. Salonia A, Capogrosso P, Boeri L, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie’s Disease. European urology. 2025;88:76-102. PMID: 40340108